Hypothyroidism abolishes the glycogenolytic effect of vasopressin, angiotensin II and A23187 but not that of alpha 1-adrenergic amines in rat hepatocytes.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001127:Arginine Vasopressin / Q000494:pharmacology*; D000001:Calcimycin / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology*; D005260:Female; D007037:Hypothyroidism / Q000378:metabolism*; D007700:Kinetics; D008099:Liver / Q000187:drug effects*; D008112:Liver Glycogen / Q000378:metabolism*; D011224:Prazosin / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains
D008112:Liver Glycogen; D011799:Quinazolines; D000804:Angiotensin II; D001127:Arginine Vasopressin; D000001:Calcimycin; D011224:Prazosin; D004837:Epinephrine